Shots:
- Roche has received a CE Mark for its Elecsys IGRA TB test, a blood-based assay for detecting tuberculosis infection (latent TB) in routine laboratory settings
- Test delivers results in <24hrs., with IGRA assay completed in 19min., & automates result calculation, interpretation, & reporting on Roche immunoassay platforms while integrating with third-party liquid handlers to streamline laboratory workflows
- In a global study, Elecsys IGRA TB demonstrated 91.1% PPA & 94.6% NPA in the intended-use population, plus 100% relative sensitivity in confirmed TB cases, & 95.3% specificity in low-risk individuals
Ref: Globenewswire | Image: Roche | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
